US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

18.60

+0.34001.86%

Pre-market: 18.900.3045+1.64%04:01 EDT

Volume:2.36M

Turnover:43.92M

Market Cap:59.20B

PE:-55.03

High:18.70

Open:18.56

Low:18.54

Close:18.26

52wk High:18.90

52wk Low:12.99

Shares:3.18B

Float Shares:3.09B

Volume Ratio:1.17

T/O Rate:0.08%

Dividend:0.65

Dividend Rate:3.47%

EPS(TTM):-0.3380

EPS(LYR):-0.3042

ROE:-2.26%

ROA:2.69%

PB:1.21

PE(LYR):-61.14

Loading ...

Overview Company News Filings

Takeda's First Female CEO Outlines Strategy for Growth Rebound and Major Product Launches

Takeda Pharmaceutical Appoints Julie Kim as Chief Executive

MT Newswires Live

Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live

Takeda Canada Says Zasocitinib Shows Superiority to Deucravacitinib in Phase 3 Psoriasis Study

MT Newswires Live

Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib

Takeda’s High-Stakes Overhaul: CEO Transition and Major Restructuring Raise Execution and Profitability Risks

Takeda presents additional results from oveporexton studies at SLEEP 2026

Takeda Pharmaceutical's Psoriasis Treatment Beats Competitor in Trial

MT Newswires Live

Takeda announces results for Phase 3 study of TAK-279

Takeda's Application for ENTYVIO IV Accepted by FDA in Pediatric Ulcerative Colitis and Crohn's Disease

MT Newswires Live

FDA accepts Takeda’s application for intravenous Entyvio

Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline

Takeda swings to FY25 net loss of JPY 152.1 billion; FY25 revenue falls 1.7% to JPY 4.51 trillion

Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story

Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch

TD Cowen Sticks to Its Buy Rating for Takeda Pharmaceutical Company (TAK)

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading

MT Newswires Live

Takeda Expands Maribavir Into Pediatric CMV, Extending Long-Term Upside Potential

Takeda Expands Real-World Data on OBIZUR, Supporting Its Rare Disease Strategy

Takeda Pharmaceutical Reportedly Found Liable in Constipation Drug Antitrust Case

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/TAK/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":18.6,"timestamp":1789416000000,"preClose":18.26,"halted":0,"volume":2357615,"hourTrading":{"tag":"盘前","latestPrice":18.9045,"preClose":18.6,"latestTime":"04:01 EDT","volume":161,"amount":3038.1044540000003,"timestamp":1789459262232,"change":0.3045,"changeRate":0.016371,"amplitude":0},"delay":0,"changeRate":0.018619934282584877,"floatShares":3092000000,"shares":3182533200,"eps":-0.338,"marketStatus":"Pre-Mkt","change":0.34,"latestTime":"09-15 06:25:26 EDT","open":18.56,"high":18.7,"low":18.54,"amount":43924545.88626,"amplitude":0.008762,"askPrice":19,"askSize":100,"bidPrice":18.72,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.338,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":18.6,"dividendRate":0.035005,"preHourTrading":{"tag":"盘前","latestPrice":18.9045,"preClose":18.6,"latestTime":"04:01 EDT","volume":161,"amount":3038.1044540000003,"timestamp":1789459262232,"change":0.3045,"changeRate":0.016371,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":18.6,"preClose":18.6,"latestTime":"19:30 EDT","volume":3894,"amount":72431.159,"timestamp":1789428606348,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.166725243408502,"impliedVol":0.3216,"impliedVolPercentile":0.42},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3092000000,"roa":"2.69%","roe":"-2.26%","lyrEps":-0.304241,"volumeRatio":1.166725243408502,"shares":3182533200,"dividePrice":0.646,"high":18.7,"amplitude":0.008762,"preClose":18.26,"low":18.54,"week52Low":12.99,"pbRate":"1.21","psRate":"1.98","week52High":18.895,"institutionHeld":0.1321,"latestPrice":18.6,"eps":-0.338,"divideRate":0.034731,"volume":2357615,"delay":0,"ttmEps":-0.338,"open":18.56,"prevYearClose":15.59,"prevWeekClose":18.26,"prevMonthClose":17.98,"prevQuarterClose":16.03,"fiveDayClose":18.45,"twentyDayClose":17.63,"sixtyDayClose":15.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2026-10-29","symbol":"TAK","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":null,"defaultRemindTime":1793260800000,"name":null,"time":"","dateTimestamp":1793246400000,"actualEps":null},{"market":"US","date":"2026-07-30","symbol":"TAK","fiscalQuarterEnding":"2026/06","expectedEps":0.41,"name":null,"time":"","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"","actualEps":0.48},{"market":"US","date":"2026-05-13","symbol":"TAK","fiscalQuarterEnding":"2026/03","expectedEps":0.21,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":0.28},{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-MKt","dateTimestamp":1761796800000,"actualEps":0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689480000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-09-14","current":-55.029586,"percent":0.020833,"low":-61.265492,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"high":247.195474,"avg":39.151803,"sd":48.510263,"marketCap":59261638939.59},"quantilePoints":[{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-20","current":80.98988,"twenty":15.819699,"median":29.842804,"eighty":45.358128,"marketCap":59032990935.72},{"date":"2026-02-27","current":81.400335,"twenty":15.819699,"median":29.842804,"eighty":45.393454,"marketCap":58849002644.08},{"date":"2026-03-06","current":79.553824,"twenty":15.819699,"median":29.842804,"eighty":45.478025,"marketCap":56940998250.88},{"date":"2026-03-13","current":79.357982,"twenty":15.819699,"median":29.842804,"eighty":45.710595,"marketCap":56281429903.04},{"date":"2026-03-20","current":80.68691,"twenty":15.819699,"median":29.842804,"eighty":45.805737,"marketCap":57640580474.28},{"date":"2026-03-27","current":81.700474,"twenty":15.819699,"median":29.842804,"eighty":45.946205,"marketCap":57787054549.19},{"date":"2026-04-02","current":82.399965,"twenty":15.819699,"median":29.842804,"eighty":46.155453,"marketCap":58414619614.42},{"date":"2026-04-10","current":80.189575,"twenty":15.819699,"median":29.842804,"eighty":46.418876,"marketCap":56894786236.46},{"date":"2026-04-17","current":78.147063,"twenty":15.819699,"median":29.842804,"eighty":46.632604,"marketCap":55443526794.1},{"date":"2026-04-24","current":74.636784,"twenty":15.819699,"median":29.842804,"eighty":46.753613,"marketCap":52882297496.5},{"date":"2026-05-01","current":73.293741,"twenty":15.819699,"median":29.842804,"eighty":47.281654,"marketCap":52807070808.15},{"date":"2026-05-08","current":72.930001,"twenty":15.819699,"median":29.842804,"eighty":47.890056,"marketCap":52641729349.45},{"date":"2026-05-15","current":43.474739,"twenty":21.105555,"median":29.8898,"eighty":48.072582,"marketCap":52716863079.61},{"date":"2026-05-22","current":42.090665,"twenty":21.242858,"median":29.981195,"eighty":48.072582,"marketCap":50702234820.63},{"date":"2026-05-29","current":42.164812,"twenty":21.619498,"median":30.013965,"eighty":48.079427,"marketCap":50785809331.9},{"date":"2026-06-05","current":40.583014,"twenty":21.679053,"median":30.061417,"eighty":48.072582,"marketCap":48640465321.16},{"date":"2026-06-12","current":41.868225,"twenty":21.919152,"median":30.109117,"eighty":48.072582,"marketCap":50028878946.35},{"date":"2026-06-18","current":41.497491,"twenty":22.002933,"median":30.148932,"eighty":48.072582,"marketCap":49432180569.37},{"date":"2026-06-26","current":-52.738505,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":49718648879.09},{"date":"2026-07-02","current":-54.677192,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":51786280766.08},{"date":"2026-07-10","current":-55.558413,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":52145787737.79},{"date":"2026-07-17","current":-56.812857,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":53292981615.83},{"date":"2026-07-24","current":-59.180349,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":55033430509.43},{"date":"2026-07-31","current":-53.86164,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55207403658.2},{"date":"2026-08-07","current":-54.125428,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55841298206.35},{"date":"2026-08-14","current":-54.819093,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":56217337436.1},{"date":"2026-08-21","current":-56.313893,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":57973616102.57},{"date":"2026-08-28","current":-56.66561,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":58133933551.36},{"date":"2026-09-04","current":-56.206423,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":59042664944.99},{"date":"2026-09-11","current":-55.356439,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":58736837078.32},{"date":"2026-09-14","current":-56.050105,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":59261638939.59}],"updateTime":1789467927053},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1152253299","title":"Takeda's First Female CEO Outlines Strategy for Growth Rebound and Major Product Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=1152253299","media":"Stock News","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152253299?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:02","pubTimestamp":1782385352,"startTime":"0","endTime":"0","summary":"The new Chief Executive Officer of Takeda Pharmaceutical Co Ltd (TAK.US), Julie Kim, has stated the company aims to return to growth within two to three years as it prepares to launch a series of new...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645984248","title":"Takeda Pharmaceutical Appoints Julie Kim as Chief Executive","url":"https://stock-news.laohu8.com/highlight/detail?id=2645984248","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645984248?lang=en_us&edition=fundamental","pubTime":"2026-06-24 15:53","pubTimestamp":1782287587,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Wednesday that it has appointed Julie Kim as president and chief executive officer.Kim succeeds Christophe Weber, who retired from both the company and its board following the annual meeting of shareholders.Kim joined Takeda in 2019 and was named CEO-elect in 2025, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645386837","title":"Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2645386837","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645386837?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:48","pubTimestamp":1782226129,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts fell Tuesday morning, tumbling 3.1% to 2,816.27 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by mobile app developer Cheetah Mobile  and pharmaceutical company Takeda Pharmaceutical , which rose 2% each. They were followed by travel company Tuniu , which was up 0.1%.The decliners from North Asia were led by fintech firm Jiayin Group  and semiconductor company ASE Technology , which fell 29.9% and 7.6% respectively. They were followed by video display maker LG Display  and semiconductor company Silicon Motion Technology , which shed 6.9% and 6.4% respectively.From South Asia, the gainers were led by IT firm Wipro  and telecommunications operator Telekomunikasi Indonesia , which increased 3.1% and 1.5% respectively. They were followed by IT firm Infosys  and pharmaceutical company Dr. Reddy's Laboratories , which advanced 1% each.The decliners from South Asia were lenders ICICI Bank  and HDFC Bank , whi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0164881194.USD","JFIN","LU0261947096.USD","LU0541501648.USD","TOUR","LU2279701549.SGD","LU0390134368.USD","LU0066902890.USD","LU0143863198.USD","LU0821914370.USD","LU0348744763.USD","LU0307460401.USD","CMCM","LU0048575426.USD","LU0251144936.SGD","LU0456842615.SGD","LU0181495838.USD","LU1868838027.USD","LU1105468828.SGD","LU0823039010.USD","SIMO","LU0143863784.USD","LU0828237940.HKD","LU0287143357.SGD","LU0431992006.USD","IE00B3M56506.USD","LU0348814723.USD","LU0898667661.SGD","BK4548","LU0333810181.USD","BK4588","BK4533","LU0541502299.USD","LU1805238398.USD","LU1102505929.USD","LU1481012133.USD","SG9999002950.SGD","INFY","LU0630378429.USD","LU0348816934.USD","LU1854104046.USD","HDB","LU2177674079.SGD","LU0918141887.USD","LU1366334651.USD","LU0536402901.SGD","LU1282648689.USD","LU1508157978.USD","BK4207","LU2663582299.SGD","LU0197773160.USD","IE00BYTNYM70.SGD","SG9999014039.USD","LU0868486357.SGD","LU0791590937.USD","BK4526","LU1366334578.USD","LU0862451753.SGD","LU0261950470.USD","LU0831103253.SGD","RDY","LU0251143458.SGD","LU0528227936.USD","LU0823038988.USD","BK4115","LU0072462343.USD","LU0797268264.HKD","LU0708995666.HKD","LU1323998911.USD","LU0531971678.HKD","LU2089985449.USD","LU0197229882.USD","BK4532","LU1267930656.SGD","SG9999014013.SGD","LU0274383776.USD","LU1048596156.SGD","LU0248272758.USD","LU0890818403.SGD","BK4142","BK4141","BK4557","LU1102505762.USD","LU0231203729.USD","LU2008162690.USD","IE00B0JY6M65.USD","IE0001KFT4U8.USD","LPL","LU0197773673.USD","LU1791710582.SGD","LU2087589342.USD","BK4535","LU2265009873.SGD","BK4134","ASX","LU2226246903.HKD","LU0048597586.USD","BK4148","IE00B7N09G41.SGD","LU1868837722.USD","LU0264410563.USD","BK4166","LU1854103824.USD","LU0630378692.HKD","LU1048588211.SGD","BK4596","TAK","BK4509","LU1868837565.USD","BK4007","LU0918141705.HKD","LU1804176565.USD","BK4023","LU0791591158.USD","BK4543","BK4523","BK4585","LU1791710400.SGD","BK4566","SG9999014005.SGD","TLK","WIT","SG9999014021.USD","IBN","SG9999004220.SGD","BK4518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645839257","title":"Takeda Canada Says Zasocitinib Shows Superiority to Deucravacitinib in Phase 3 Psoriasis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2645839257","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645839257?lang=en_us&edition=fundamental","pubTime":"2026-06-23 21:01","pubTimestamp":1782219674,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical's (TAK) Canadian unit, Takeda Canada, said Tuesday that its investigational oral tyrosine kinase 2 inhibitor zasocitinib showed \"statistical superiority\" over deucravacitinib for","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645836029","title":"Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2645836029","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645836029?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:40","pubTimestamp":1782218451,"startTime":"0","endTime":"0","summary":"Takeda (TAK) Canada is pleased to announce positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasociti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-canada-reports-positive-results-from-phase-3-study-of-zasocitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-canada-reports-positive-results-from-phase-3-study-of-zasocitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644724607","title":"Takeda’s High-Stakes Overhaul: CEO Transition and Major Restructuring Raise Execution and Profitability Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2644724607","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644724607?lang=en_us&edition=fundamental","pubTime":"2026-06-18 14:00","pubTimestamp":1781762411,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company (TAK) has disclosed a new risk, in the Corporate Activity and Growth category. Takeda Pharmaceutical Company faces ex...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-high-stakes-overhaul-ceo-transition-and-major-restructuring-raise-execution-and-profitability-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-high-stakes-overhaul-ceo-transition-and-major-restructuring-raise-execution-and-profitability-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643207813","title":"Takeda presents additional results from oveporexton studies at SLEEP 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643207813","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643207813?lang=en_us&edition=fundamental","pubTime":"2026-06-16 00:05","pubTimestamp":1781539552,"startTime":"0","endTime":"0","summary":"Takeda (TAK) presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton, an oral orexin receptor 2-selective agonist,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-presents-additional-results-from-oveporexton-studies-at-sleep-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-presents-additional-results-from-oveporexton-studies-at-sleep-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281322","title":"Takeda Pharmaceutical's Psoriasis Treatment Beats Competitor in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281322","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642281322?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:54","pubTimestamp":1781178848,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Thursday its experimental psoriasis medication zasocitinib outperformed competing drug deucravacitinib in a phase 3 clinical trial.More than 35% of individuals given the daily oral therapy reached total skin clearance after 16 weeks, more than 2.5 times the response rate for deucravacitinib, the company said.The trial met its primary and secondary endpoints while showing a safety profile consistent with prior research, and the company intends to submit a regulatory approval request within the fiscal year, Takeda said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642896372","title":"Takeda announces results for Phase 3 study of TAK-279","url":"https://stock-news.laohu8.com/highlight/detail?id=2642896372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642896372?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:12","pubTimestamp":1781176351,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib, TAK-279, an inv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-results-for-phase-3-study-of-tak-279-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-results-for-phase-3-study-of-tak-279-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642490543","title":"Takeda's Application for ENTYVIO IV Accepted by FDA in Pediatric Ulcerative Colitis and Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2642490543","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642490543?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:59","pubTimestamp":1781038794,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said late Tuesday the US Food and Drug Administration has accepted for review its supplemental biologics license application for intravenous ENTYVIO for the treatment of moderate to severely active ulcerative colitis and Crohn's disease in pediatric patients aged 2 years and older.If approved, ENTYVIO would be the only gut-focused treatment option for these patients, the company said.The FDA has set a Prescription Drug User Fee Act goal date in Q1 2027.Takeda said it has also submitted a marketing authorization application to the European Medicines Agency for ENTYVIO IV to treat pediatric patients aged 2 years and older.ENTYVIO is currently approved for the treatment of moderate to severely active UC and Crohn's disease in adults.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4585","LABU","TAK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642977044","title":"FDA accepts Takeda’s application for intravenous Entyvio","url":"https://stock-news.laohu8.com/highlight/detail?id=2642977044","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642977044?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:37","pubTimestamp":1781037420,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced the U.S. Food and Drug Administration has accepted for review its supplemental Biologics License Application for intravenous...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-accepts-takedas-application-for-intravenous-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-accepts-takedas-application-for-intravenous-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","TAK","BK4007","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642875491","title":"Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2642875491","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642875491?lang=en_us&edition=fundamental","pubTime":"2026-06-10 00:30","pubTimestamp":1781022647,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is moving ahead with a phase 2 trial of TAK-360 fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-tak-360-narcolepsy-trial-moves-forward-expanding-its-specialty-cns-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-tak-360-narcolepsy-trial-moves-forward-expanding-its-specialty-cns-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111946","title":"Takeda swings to FY25 net loss of JPY 152.1 billion; FY25 revenue falls 1.7% to JPY 4.51 trillion","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641111946?lang=en_us&edition=fundamental","pubTime":"2026-06-05 17:51","pubTimestamp":1780653060,"startTime":"0","endTime":"0","summary":"Takeda posted FY2025 revenue of JPY 4.51 trillion, down 1.7%, while operating profit dropped 98.2% to JPY 6.2 billion.It turned to a net loss attributable to owners of JPY 152.4 billion; basic EPS was a loss of JPY 96.75.Other operating expenses widened to JPY 559 billion, driven by a JPY 403.5 billion provision tied to the AMITIZA antitrust verdict.It booked an additional legal provision of JPY 402.5 billion with related tax benefits of JPY 58.4 billion; the FY2025 year-end dividend stayed JPY 100.FY2026 forecast was unchanged, targeting revenue of JPY 4.64 trillion with operating profit of JPY 420 billion; dividend guidance remains JPY 204.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Takeda Pharmaceutical Co. Ltd. published the or","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDLbb0RFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169669","title":"Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169669?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:33","pubTimestamp":1780590839,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) has launched a new Phase 2 trial called “A D...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-new-mezagitamab-trial-targets-high-risk-kidney-rejection-bolstering-long-term-pipeline-story?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-new-mezagitamab-trial-targets-high-risk-kidney-rejection-bolstering-long-term-pipeline-story?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641616965","title":"Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2641616965","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641616965?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:33","pubTimestamp":1780590827,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running an observational study in Argenti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-real-world-maribavir-study-in-argentina-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-real-world-maribavir-study-in-argentina-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4211","TAK","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640980134","title":"TD Cowen Sticks to Its Buy Rating for Takeda Pharmaceutical Company (TAK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640980134","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640980134?lang=en_us&edition=fundamental","pubTime":"2026-06-04 13:26","pubTimestamp":1780550778,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Nedelcovych from TD Cowen maintained a Buy rating on Takeda Pharmaceutical Company, with a price target of $21....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-its-buy-rating-for-takeda-pharmaceutical-company-tak-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-its-buy-rating-for-takeda-pharmaceutical-company-tak-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TD","TAK","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950223","title":"Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950223","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640950223?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:40","pubTimestamp":1780324839,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts opened the trading week sharply higher Monday morning, rising 1.19% to 2,889.22 on the S&P Asia 50 ADR Index.From North Asia, the gainer","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0175139822.USD","LU1267930656.SGD","BK4577","LU0890818403.SGD","BK4509","LU0516422440.USD","EVS.SI","LU0264606111.USD","LU0979878070.USD","BK4533","LU0536402901.SGD","LU2045819591.USD","LU1868838027.USD","09866","SG9999006266.SGD","LU1366334578.USD","LU0143863784.USD","LU0683595622.HKD","SG9999013486.USD","BK4510","BK4548","BK4164","LU0251143029.SGD","LU0048573645.USD","LU0823038988.USD","BK4588","LU0572939691.SGD","BK4596","TAK","INFY","LU0143863198.USD","LU0532188223.SGD","LU0248272758.USD","LU2476274720.SGD","LU0898667661.SGD","IE00B0JY6M65.USD","LU1242518931.SGD","SG9999002620.SGD","LU0828237940.HKD","BK4170","LU0791591158.USD","SG9999002414.USD","TLK","LU0066902890.USD","BK4166","LU1981816686.USD","IBN","LU0516422366.SGD","LU0823039010.USD","LU2087589342.USD","BK4519","PHI","LU0708995583.HKD","LU2125910500.SGD","SE","LU0264410563.USD","LU0737861269.HKD","SG9999002406.SGD","BK4534","BK4557","LU0333810181.USD","03660","LU0831103253.SGD","LU0287143357.SGD","NIO","LU2065171311.SGD","LU1861220207.SGD","BK4523","DXF","LU1366334651.USD","BK4581","LU0431992006.USD","LU0345775950.USD","LU0181495838.USD","LU2360107671.USD","BK4089","CAN","BK4503","LU1323998911.USD","LU0210637038.USD","LU0516423091.SGD","SG9999014484.SGD","LU0516423174.USD","BK4132","LU1861217088.USD","LU2065171402.SGD","BK4513","LU1868837565.USD","BK4023","LU2543165471.USD","LU0320764599.SGD","IE00B7N09G41.SGD","LU1048596156.SGD","LU1805238398.USD","RDY","LU0345776255.USD","SG9999004220.SGD","BK4141","BK4555","LU0261950470.USD","SIFY","BK4134","IE0001KFT4U8.USD","BK4085","LU0589944569.HKD","LU0633140560.USD","LU1048588211.SGD","SGXZ58947870.SGD","BK4532","LU0708995666.HKD","LU0541501648.USD","LU0261945553.USD","LU2663582299.SGD","SG9999001135.SGD","LU0821914370.USD","SG9999002604.SGD","SG9999005177.SGD","LU0441851309.USD","BILI","LU0572940350.SGD","09626","LU0048575426.USD","LU2065170008.USD","LU0048597586.USD","SG9999004360.SGD","BK4504","IE00BYTNYM70.SGD","BK4220","LU1770036033.HKD","LU2476274308.USD","LU0261947096.USD","BK4531","LU0307460401.USD","BK4600","LU0499858602.USD","SG9999013460.SGD","BK4551","BK4595","QFIN","BK4077","LU1102505929.USD","LU0289960550.SGD","LU0862451753.SGD","LU0516422952.EUR","LU1481012133.USD","SG9999014492.USD","BK4115","BK4526","LU0791590937.USD","BK4574","BK4007","HIMX","LU1242518857.USD","LU2778985437.USD","LU2125910849.SGD","LU2065169927.USD","NIOG","LU1804176565.USD","BK4535","BK4554","LU0499858438.USD","IE00B3M56506.USD","JKS","LU0052750758.USD","LU0531971678.HKD","LU1868837722.USD","LU1808992512.USD","SG9999002679.SGD","LU0197229882.USD","IE0031814969.USD","LU0348744763.USD","CMCM","LU0348788117.USD","BK4099","LU2008162690.USD","LU2177674079.SGD","NIO.SI","LU2152927971.USD","BK4566","BK4563","LU0231203729.USD","LU0251143458.SGD","IE00BD6J9T35.USD","LU0251144936.SGD","LU2265009873.SGD","LU0633140727.USD","LU1508157978.USD","BK4585","LU1102505762.USD","BK4207","LU1839390173.USD","LU0072462343.USD","LU2238330802.EUR","SG9999013478.USD","LU0868486357.SGD","IE0034224299.USD","LU0541502299.USD","BK4505","LU0164881194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334502","title":"Takeda Expands Maribavir Into Pediatric CMV, Extending Long-Term Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334502","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637334502?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:35","pubTimestamp":1779467740,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a Phase 3 trial (NCT05319353) to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-expands-maribavir-into-pediatric-cmv-extending-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-expands-maribavir-into-pediatric-cmv-extending-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637834507","title":"Takeda Expands Real-World Data on OBIZUR, Supporting Its Rare Disease Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2637834507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637834507?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:32","pubTimestamp":1779467567,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running an observational study in Japan t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-expands-real-world-data-on-obizur-supporting-its-rare-disease-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-expands-real-world-data-on-obizur-supporting-its-rare-disease-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883147","title":"Takeda Pharmaceutical Reportedly Found Liable in Constipation Drug Antitrust Case","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883147","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636883147?lang=en_us&edition=fundamental","pubTime":"2026-05-19 17:13","pubTimestamp":1779181993,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  was found liable by a US jury for using an anticompetitive agreement to delay a generic version of its constipation drug Amitiza, according to media reports Monday.The verdict, delivered in the US District Court for the District of Massachusetts, stemmed from claims that Takeda and former partner Sucampo Pharmaceuticals entered into a \"pay-for-delay\" settlement with Par Pharmaceutical that postponed generic competition for years, Reuters reported.Takeda Pharmaceutical said damages awarded to wholesaler and retailer plaintiffs are subject to automatic trebling under US antitrust law upon entry of judgment.The company said it plans to appeal the ruling and believes the trial included both legal and evidentiary errors.\"We remain firm in our conviction that the plaintiffs' case lacks merit, and we will vigorously pursue post-trial motions and an appeal,\" the company said in a statement.Takeda Pharmaceutical said the jury verdict will not have any impact on its 2025 f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":92,"code":"91000000","status":"200"}]}}